These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24842468)

  • 1. Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis.
    Kim B; Kang S; Jeong G; Park SB; Kim SJ
    PLoS One; 2014; 9(5):e97818. PubMed ID: 24842468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
    Ying J; Poon FF; Yu J; Geng H; Wong AH; Qiu GH; Goh HK; Rha SY; Tian L; Chan AT; Sung JJ; Tao Q
    Br J Cancer; 2009 Feb; 100(4):663-9. PubMed ID: 19156137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
    Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
    PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer.
    Kang S; Kim B; Park SB; Jeong G; Kang HS; Liu R; Kim SJ
    Int J Oncol; 2013 Nov; 43(5):1659-65. PubMed ID: 24026393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.
    Irizarry RA; Ladd-Acosta C; Wen B; Wu Z; Montano C; Onyango P; Cui H; Gabo K; Rongione M; Webster M; Ji H; Potash J; Sabunciyan S; Feinberg AP
    Nat Genet; 2009 Feb; 41(2):178-186. PubMed ID: 19151715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
    Yang Y; Chu FH; Xu WR; Sun JQ; Sun X; Ma XM; Yu MW; Yang GW; Wang XM
    Medicine (Baltimore); 2017 Nov; 96(47):e8487. PubMed ID: 29381923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
    Mori Y; Cai K; Cheng Y; Wang S; Paun B; Hamilton JP; Jin Z; Sato F; Berki AT; Kan T; Ito T; Mantzur C; Abraham JM; Meltzer SJ
    Gastroenterology; 2006 Sep; 131(3):797-808. PubMed ID: 16952549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal losses are associated with hypomethylation of the gene-control regions in the stomach with a low number of active genes.
    Jung YC; Hong SJ; Kim YH; Kim SJ; Kang SJ; Choi SW; Rhyu MG
    J Korean Med Sci; 2008 Dec; 23(6):1068-89. PubMed ID: 19119454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
    Kim JH; Kang HS; Kim TW; Kim SJ
    Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
    de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
    BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation markers for diagnosis and prognosis of common cancers.
    Hao X; Luo H; Krawczyk M; Wei W; Wang W; Wang J; Flagg K; Hou J; Zhang H; Yi S; Jafari M; Lin D; Chung C; Caughey BA; Li G; Dhar D; Shi W; Zheng L; Hou R; Zhu J; Zhao L; Fu X; Zhang E; Zhang C; Zhu JK; Karin M; Xu RH; Zhang K
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7414-7419. PubMed ID: 28652331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.